Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, and Amplitude Healthcare Acquisition Corporation, a special purpose acquisition company sponsored by affiliates of Avego Management, LLC and Metalmark Capital, today announced that Lawrence Klein, Ph.D., and Chris Nolet will be appointed to Jasper Therapeutics’ board of directors, effective ...
KEYTRUDA Is First Anti-PD-1/PD-L1 Therapy to Show Overall Survival Improvement in Combination With Chemotherapy With or Without Bevacizumab in These Patients Results From Phase 3 KEYNOTE-826 Trial Selected for Official Press Program and Presentation During Presidential Symposium at ESMO Congress 2021 and Simultaneously Published in New England Journal of Medicine KENILWORTH, N.J.---- Merck (MRK), kno...
Xeris Pharmaceuticals, Inc. (XERS) today announced that its stockholders have voted to approve the previously announced proposed acquisition of Strongbridge Biopharma plc (SBBP) by Xeris.
Soaring Eagle Shareholder Approval Obtained, Closing Scheduled for September 16, 2021 Ginkgo Set to Begin Trading under NYSE: DNA on September 17, 2021 NEW YORK---- Soaring Eagle Acquisition Corp. (SRNG) announced today that its business combination with Ginkgo Bioworks, Inc. was overwhelmingly approved in a shareholder vote held this morning, with 75% of shareholders participating in the vote and 97%...
- Advances Partnership Aimed at Streamlining Cannabis and CBD Cultivator Production, Safety Standards, and Traceability While Increasing Brand Recognition - Applied DNA Sciences, Inc. (APDN), a leader in Polymerase Chain Reaction-based DNA manufacturing and nucleic acid-based technologies, today announced that its CertainT® platform has added support for StrainSecure 2.0 by TruTrace Technologies, Inc....
Acquisition expands AbCelleras existing capabilities to unlock difficult-to-drug transmembrane proteins for antibody discovery programs AbCellera, a technology company with a centralized operating system for next-generation antibody discovery, today announced it has acquired TetraGenetics, Inc., a biotechnology company with a proprietary platform for generating recombinant human ion channels a...
Aditxt, Inc. (ADTX), a biotech innovation company with a mission to improve the health of the immune system, today announced it has closed on a registered direct offering for $11 million announced on August 26, 2021 and funded a bridge loan to its acquisition target, satisfying a key term of the Letter of Intent.
Common stock and warrants of the combined company, renamed Renovacor, Inc., will commence trading on September 3, 2021 on the NYSE under ticker symbols “RCOR” and “RCOR.WS”, respectively. Gross proceeds from the transaction totaled approximately $95.1 million.
AscellaHealth, a global specialty pharmacy and healthcare solutions company, announces its innovative newsletter, Developments in Specialty Pharmacy, featuring insights, perspectives and solutions for utilization of expensive specialty drugs and gene therapies that address complex diseases, as well as orphan and rare disorders and in-depth, exclusive interviews with industry partners, such as t...
Catalent, Inc. (CTLT), the leading global provider of development sciences and manufacturing platforms for medicines, including biotherapeutics; cell and gene therapies; and consumer health products, today announced that it has reached an agreement to acquire Bettera Holdings, LLC, a major manufacturer in the high-growth gummy, soft chew, and lozenge segments of the nutritional supplements market, for...
News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.
PDF’s require Adobe® Reader® and will open in a new window.
Log In Required
